Dalia Al Saeedy successfully defends her MDD thesis on modulating UGT1A1 gene to enhance camptothecin’s anti-colorectal effects

Dalia Al Saeedy, a student in the Master of Science in Drug Discovery and Development program at the College of Pharmacy, has successfully defended her thesis titled “Modulating the Polymorphic UGT1A1 Gene to Enhance Captothecin’s Anti-Colorectal Effect”.

The examination committee was led by Dr. Ahmed Al-Abd, Professor of Pharmacology and Toxicology and the main supervisor of the thesis. The examiners included Dr. Steven Shnyder, Associate Professor at the School of Pharmacy and Medical Sciences at the University of Bradford, UK, Dr. Muhammad AlShorbagy, Associate Professor of Pharmacology and Toxicology at the College of Pharmacy at Gulf Medical University, and Dr. Walid Elsayed, Associate Professor of Oral Histopathology at the College of Dentistry at Gulf Medical University.

gmu

The oral defense examination was held in front of a panel of experts in the field of pharmacology and drug development. After a thorough and rigorous defense, the examination committee agreed that Dalia had successfully demonstrated a deep understanding of her research topic and had successfully completed her thesis.

This is a major accomplishment for Dalia, and we congratulate Dalia on her hard work and dedication to her studies. We wish Dalia all the best in her future endeavors in the field of drug discovery and development.